Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Molecular Pharmacology 2019

About Conference

Conference Series LLC Ltd invites you to attend “Molecular Pharmacology 2019” to be held on May 01-02, 2019 at Amsterdam, Netherlands. The scientific-program is an ironic grouping of formats ranging from keynote sessions containing many well-known and thought provoking speakers to intense and highly interactive discussion sessions.


Molecular Pharmacology 2019 will bring together an interdisciplinary group of professionals working in the field of Molecular Pharmacology. Major professional groups included: Molecular Pharmacology researchers, Professors, Directors, Young researchers. The field of Molecular Pharmacology growing rapidly and its development is making tremendous impacts in development of prescription drugs. The importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors.

Why to Attend

The Molecular Pharmacology serves members applying approaches of biochemistry, biophysics, genetics, and molecular biology to study molecular mechanisms of drug action, regardless of the class of drug. Areas of interest include: drug receptor-effector coupling and its regulation (e.g. receptor structure/function, G proteins, kinases, phosphatases, and second messenger synthesis and degradation), voltage- and ligand-gated ion channels, antimicrobial and antineoplastic drug action, steroid and growth factor receptors, gene regulation, and identification of molecular targets for drugs.

Conference series llc LTD organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publish 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Market Analysis

The development, production and marketing of medications are the main responsible of Pharmaceutical Industry. The global pharmaceutical industry revenue is forecasted to reach an estimated $934.8 billion by 2017 and it is expected to reach USD 1.12 trillion by the end of 2025, with a CAGR of 6.3% during 2018-2025. The industry is expected to Increase growth led by increasing population, changing lifestyles, hectic daily activities, unhealthy eating habits, increasing the work pressure, increasing incidence of chronic diseases across the entire global population providing growth opportunities for the industry players.

The large portion of this revenue is generating from North America due to the role of the U.S. pharmaceutical industry.

Target Audience/Opportunites


Target Audience:


Molecular Biologists

Molecular Pharmacologist Faculty

Medical Scientist

Pharmacologist Faculty

Clinical Pharmacologist

Molecular Mechanisms of Pain

Biochemical Pharmacologist

Pharmacologist Students, Scientists

Pharmacology and Neurology

Relevant Association and Societies

biomedical science

Pharmaceuticals Company

Pharma Colleges

Business Professionals (Directors, presidents, CEO) from Pharmacology market




For Researchers and Faculty members:

Speaker Presentation

Poster Presentation

Symposium Hosting

Workshop Organizing

Special Sessions Presentation


For Universities, Associations & Societies:

Association Partnering

Collaboration Proposals

Academic Partnering

Group Participation


For students and Research Scholars:

Poster Competition

Young Researcher Forum

Student Attendee

Group Registrations


For Business Delegates:

Speaker Presentations

Symposium Hosting

Book Launch Event

Networking Opportunities

Audience Participation


For product manufacturers:

Exhibitor and Vendor Booths

Sponsorship Opportunities

Product Launch

Workshop Organization

Scientific Partnering

Marketing and Networking with Clients



Pharmacology is the study of drugs, which includes their mode of action, their breakdown in the body and their interaction with other drugs. Professionals in this field can work for research laboratories, colleges and universities, as well as for government agencies, such as the National Institutes of Health and the US Food and Drug Administration.

  • Pharmacologist
  • Clinical Pharmacologist
  • Veterinary Pharmacologist
  • Medical Scientist
  • Professor


Molecular Pharmacology

The discipline of pharmacology examines drugs in order to determine how they actually work in a living organism. To do this, molecular pharmacology uses molecular biology methods. Molecular biology studies macromolecules essential for life, such as nucleic acids and proteins. In general, students interested in studying molecular pharmacology need knowledge in disciplines such as neuroscience, cell biology, immunology and biochemistry.

Current medical conditions involved in research in molecular pharmacology include various types of cancer, cardiovascular disease, Alzheimer's and Parkinson's, as well as addiction.

  • Molecular Biologist
  • Medical Scientist
  • Clinical Pharmacologist



Neuropharmacology is the study of the interaction of drugs with the nervous system, including the spinal cord, nerves and brain. In the field of neuropharmacology, individuals are working on the development of new drugs to treat neurochemical disorders, and they are often tasked with assessing the level of efficacy and overall safety of new psychiatric drugs. Professionals trained in neuropharmacology could investigate the neurological effects of drugs such as anaesthetics, psycho-stimulants, and nicotine on the human body, including how drugs affect behaviour, senses, mood, and memory. The neuropharmacology study includes specializations in areas such as neurotransmission, drug neurotoxicity, nervous system disorders and behavioural pharmacology, to name a few.

  • Clinical Pharmacologist
  • Pharmacologist
  • Neuroscientist
  • Psychiatrist
  • Clinical Research Analyst



Psychopharmacology is the study of the effects of psychotropic drugs in the treatment of mental illness. This is a complex area of ​​study involving topics such as pharmacokinetics and pharmacodynamics - how body chemistry affects drugs and how drugs affect the body. Underestimation of neuroscience and clinical medicine as well as diagnostic and treatment options for patients is essential for the study of pharmacology. The American Society of Clinical Psychopharmacology (ASCP) reports that doctors, psychiatrists and researchers at the doctoral level are all considered psychopharmacologists.

  • Psychiatrist
  • General Physician
  • Medical Scientist
  • Registered Nurse
  • Child Psychiatrist
  • Clinical Psychologist
  • Psychiatric Nurse Practitioner



Toxicologists investigate hazardous chemicals, researching and testing their effects on the human body and the environment. Toxicologists analyse chemicals found in food, drugs, water and air and measure their risks by determining the levels of concentration in which they threaten human and environmental health. Toxicologists help communicate these risks by formulating safety standards for new products and overseeing regulatory compliance with these safety standards.

  • Forensic Toxicologist
  • Environmental Toxicologist
  • Veterinary Pathologist
  • Toxicologist
  • Staff Toxicologist
  • Pharmacologist
  • Clinical Research Scientist
  • Environmental Health and Safety Specialist


Clinical Pharmacology

Clinical pharmacologists are physicians, pharmacists and scientists who focus on developing and understanding new drug therapies. Clinical pharmacologists work in a variety of academic, industrial and government settings. In the laboratory, they study biomarkers, pharmacokinetics, drug metabolism and genetics. In offices, they design and evaluate clinical trials, develop and implement guidelines for drug regulation, and review drug use locally and globally. In a clinical setting, they work directly with patients, participate in experimental studies, and study adverse effects and interactions.

  • Clinical pharmacologists
  • Clinical Staff Pharmacologists
  • Clinical Research Scientist


Molecular and Cellular Pharmacology

The cells are as complex as they are tiny, and much is still unknown about the inner workings of these life building blocks. Biology is the study of living things, and cellular or molecular biology studies living things on the smallest possible scale. The research of cellular and molecular biologists is integral to the development of new drugs, the protection of aquatic ecosystems and the improvement of agricultural products.

  • Molecular Cell Biology
  • Cell Biologist
  • Cellular Biologist
  • Molecular Biologist


Cardiovascular pharmacology

The cardiovascular system is the railway system of the body. It transports nutrients to all the organs and tissues to keep them supplied with energy in much the same way trains transport supplies across the country. When this system shuts down, the organs and tissues begin to starve. This can occur when the vessels that transport the nutrients get clogged and the blood can't get through, or when the heart stops pumping properly and is no longer able to provide enough force to push the blood through this intricate network of vessels. There are many things we can do as individuals to keep this railway system working at its best including eating properly, avoiding smoking, and exercising regularly, but sometimes that just is not enough. For many people, medications are necessary to prevent the cardiovascular system from backing up or shutting down all together.

  • Atherosclerosis
  • Hypertension
  • Angina         
  • Arrhythmia



Pharmacogenetics is the study of how people react to pharmacotherapy. Although this science is still new, many useful discoveries have been made. It has long been known that genes influence the risk of developing certain diseases, or that these genes could determine characteristics such as the colour of hair and eyes. Genes can also alter the risk of developing different diseases. More recently, discoveries have shown that genes can determine other aspects of each individual, up to the level of the enzymes produced in the liver. Since these enzymes determine the rate at which a drug is removed from the body, they can make a significant difference in the way people respond to drugs. Some of the most basic work deals with how race and gender influence drug reactions - and race and gender are genetically determined.

  • Enzyme
  • Metabolism
  • Sickle cell Anaemia



In pharmacogenomics, genomic information is used to study individual drug responses. When a genetic variant is associated with a particular drug response in a patient, it is possible to make genetic-based clinical decisions by adjusting the dosage or choosing a different drug, for example. Scientists evaluate genetic variants that affect an individual's response to a drug in the same way that they evaluate genetic variants associated with diseases: by identifying genetic loci associated with known drug responses and then testing individuals who’s the answer is unknown. Modern approaches include multigene analysis or whole genome single nucleotide polymorphism (SNP) profiles, and these approaches are just beginning to be used clinically for drug discovery and development.


Safety pharmacology

Safety pharmacology is a rapidly evolving discipline that uses the basic principles of pharmacology as part of a regulatory process to produce data to inform the assessment of risks and benefits. The goal of safety pharmacology is to characterize the pharmacodynamics / pharmacokinetic (PC / PD) relationship of adverse drug reactions using a constantly evolving methodology. Unlike toxicology, safety pharmacology includes a regulatory requirement to predict the risk of rare fatal events. This is what makes pharmacology safe and unique. The key questions for pharmacology of safety are the detection of an adverse event, the projection of the data into the calculation of the safety margin and, finally, the monitoring of clinical safety.

  • The detection of adverse effects liability
  • Investigation of the mechanism of effect
  • Calculating a projected safety margin
  • Implications for clinical safety monitoring
  • Mitigation strategies (risk management)

To Collaborate Scientific Professionals around the World

Conference Date May 01-02, 2019

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by